NO20092597L - Renininhibitorer for prevensjon og behandling av hypertensjon hos overvektige pasienter - Google Patents

Renininhibitorer for prevensjon og behandling av hypertensjon hos overvektige pasienter

Info

Publication number
NO20092597L
NO20092597L NO20092597A NO20092597A NO20092597L NO 20092597 L NO20092597 L NO 20092597L NO 20092597 A NO20092597 A NO 20092597A NO 20092597 A NO20092597 A NO 20092597A NO 20092597 L NO20092597 L NO 20092597L
Authority
NO
Norway
Prior art keywords
obese patients
hypertension
prevention
treatment
renin inhibitors
Prior art date
Application number
NO20092597A
Other languages
English (en)
Norwegian (no)
Inventor
Margaret Forney
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39186152&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20092597(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20092597L publication Critical patent/NO20092597L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20092597A 2006-12-15 2009-07-08 Renininhibitorer for prevensjon og behandling av hypertensjon hos overvektige pasienter NO20092597L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87018006P 2006-12-15 2006-12-15
PCT/US2007/087322 WO2008074001A1 (fr) 2006-12-15 2007-12-13 Inhibiteurs de rénine pour la prévention et le traitement de l'hypertension chez les patients obèses

Publications (1)

Publication Number Publication Date
NO20092597L true NO20092597L (no) 2009-07-13

Family

ID=39186152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092597A NO20092597L (no) 2006-12-15 2009-07-08 Renininhibitorer for prevensjon og behandling av hypertensjon hos overvektige pasienter

Country Status (18)

Country Link
US (1) US20100029775A1 (fr)
EP (1) EP2094259A1 (fr)
JP (1) JP2010513300A (fr)
KR (1) KR20090090384A (fr)
CN (1) CN101583355A (fr)
AU (1) AU2007333095B2 (fr)
BR (1) BRPI0721167A2 (fr)
CA (1) CA2672579A1 (fr)
CL (1) CL2007003628A1 (fr)
IL (1) IL198876A0 (fr)
MA (1) MA31003B1 (fr)
MX (1) MX2009006340A (fr)
NO (1) NO20092597L (fr)
RU (1) RU2009126741A (fr)
TN (1) TN2009000240A1 (fr)
TW (1) TW200831071A (fr)
WO (1) WO2008074001A1 (fr)
ZA (1) ZA200903442B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143425A1 (fr) * 2008-07-11 2010-01-13 Ratiopharm GmbH Tablettes d'aliskiren comprimées directement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
AR047880A1 (es) * 2004-02-17 2006-03-01 Novartis Ag COMBINACIoN DE UN INHIBIDOR DE RENINA Y DIURÉTICOS
TW200605867A (en) * 2004-03-17 2006-02-16 Novartis Ag Use of organic compounds
WO2007047351A2 (fr) * 2005-10-13 2007-04-26 Orexigen Therapeutics, Inc. Méthodes pour traiter l'hypertension chez des individus en surpoids et obèses
CA2655144A1 (fr) * 2006-06-15 2007-12-21 Gilead Colorado, Inc. Procede de traitement antihypertenseur

Also Published As

Publication number Publication date
CL2007003628A1 (es) 2008-07-18
MX2009006340A (es) 2009-06-23
EP2094259A1 (fr) 2009-09-02
TW200831071A (en) 2008-08-01
KR20090090384A (ko) 2009-08-25
IL198876A0 (en) 2010-02-17
MA31003B1 (fr) 2009-12-01
WO2008074001A1 (fr) 2008-06-19
TN2009000240A1 (en) 2010-10-18
AU2007333095B2 (en) 2011-03-24
RU2009126741A (ru) 2011-01-20
WO2008074001A8 (fr) 2009-07-02
US20100029775A1 (en) 2010-02-04
BRPI0721167A2 (pt) 2014-03-18
AU2007333095A1 (en) 2008-06-19
JP2010513300A (ja) 2010-04-30
CA2672579A1 (fr) 2008-06-19
CN101583355A (zh) 2009-11-18
ZA200903442B (en) 2010-05-26

Similar Documents

Publication Publication Date Title
NO20084256L (no) DPP IV inhibitorformuleringer
WO2010074588A8 (fr) Composés pharmaceutiques
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
WO2005023179A3 (fr) Methodes combinees de traitement du cancer
NO20060398L (no) Anvendelse av en kombinasjon av en epidermal vekstfaktor reseptor kinase inhibitor og cytotoksiske midler for behandling og hemming av kreft
WO2010039538A3 (fr) Inhibiteur de flavivirus et procédés d'utilisation de ceux-ci
WO2005049084A3 (fr) Inhibition de canaux trp comme traitement contre l'hypertrophie et l'insuffisance cardiaques
NO20053455L (no) Anvendelse av en kombinasjon inneholdende en ikke-nukleosid revers transkriptase inhibitor (NNRTI) med en inhibitor av cytokrom P450 sa som protease inhibitorer
ATE555810T1 (de) Mittel zur behandlung oder prävention von verdauungsgeschwüren
CL2008001782A1 (es) Uso de una composicion que comprende un compuesto derivado de heterociclo para tratar o prevenir la perdida de flujo intestinal; composicion que comprende dicho compusto; y kit que comprende la composicion.
AU2008267058A8 (en) Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
ZA200806778B (en) N-Hydroxyacrylamide compounds
WO2007101232A3 (fr) Inhibition de jak2 pour traiter l'hypertension artérielle pulmonaire
NO20090322L (no) 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor
ATE551052T1 (de) Verwendung von reninhemmern zur prävention oder behandlung von diastolischer dysfunktion oder diastolischer herzinsuffizienz
WO2003092606A3 (fr) Inhibiteurs de cholinesterase pour prevenir les blessures causees par des produits chimiques
WO2014186623A3 (fr) Méthodes et compositions pour le traitement de la maladie de chagas
WO2007044325A3 (fr) Inhibiteurs de l'interaction du domaine apoe4 et methodes d'utilisation
WO2004052236A3 (fr) Methodes et compositions de traitement de l'otite moyenne
EA200970164A1 (ru) Ингибиторы каспазы на основе пиридазинонового каркаса
RS54185B1 (en) USE OF 24-ORDER
NO20073104L (no) Anvendelse av en 5-HT6 agonist for behandling og forebygging av neurodegenerative forstyrrelser
NO20092597L (no) Renininhibitorer for prevensjon og behandling av hypertensjon hos overvektige pasienter
ATE547105T1 (de) Glucosamin und derivate davon als transglutaminase-inhibitoren zur verwendung in der behandlung von einer funktionsstörung des nervensystems
WO2008061647A8 (fr) Utilisation d'un composé comme inhibiteur de vegf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application